7.83
Amneal Pharmaceuticals Inc Aktie (AMRX) Neueste Nachrichten
What makes Amneal Pharmaceuticals Inc. stock price move sharplyTransform your portfolio with high-yield stocks - jammulinksnews.com
What is Amneal Pharmaceuticals Inc. company’s growth strategyAccelerated profit realization - jammulinksnews.com
What are the technical indicators suggesting about Amneal Pharmaceuticals Inc.Free Investment Community - jammulinksnews.com
What analysts say about Amneal Pharmaceuticals Inc. stockStay informed with daily expert analysis - jammulinksnews.com
Is Amneal Pharmaceuticals Inc. a growth stock or a value stockTremendous growth opportunities - jammulinksnews.com
What are Amneal Pharmaceuticals Inc. company’s key revenue driversExponentially increasing returns - jammulinksnews.com
What is the dividend policy of Amneal Pharmaceuticals Inc. stockUnlock your portfolio’s full growth potential - jammulinksnews.com
Teva, Amneal rated Buy, Viatris Neutral as Goldman Sachs reviews generics space - MSN
What drives Amneal Pharmaceuticals Inc. stock priceDiscover high-impact stocks for growth - jammulinksnews.com
Truist Financial Keeps Buy Rating on Amneal Pharmaceuticals with $8 PT - AInvest
Amneal Pharmaceuticals Secures $2.1 Billion in Loans - TipRanks
How does Amneal Pharmaceuticals Inc. compare to its industry peersBest Dividend Report From AI Tools - jammulinksnews.com
How strong is Amneal Pharmaceuticals Inc. company’s balance sheetMarket Forecast Signals For Fast Growth - jammulinksnews.com
Truist Financial Maintains a Buy on Amneal Pharmaceuticals (AMRX) With an $8 PT - Insider Monkey
Amneal Launches GLP-1 Agonist Exenatide Injection - Specialty Pharmacy Continuum
Teva Drops Inhaler Patent Infringement Lawsuit Against Amneal - Bloomberg Law News
Is Amneal Pharmaceuticals Inc. a candidate for recovery playReversal Alert Based on RSI Indicator Confirmed - metal.it
Amneal Pharmaceuticals Inc. Company’s Quarterly Earnings Growth: What the Numbers SayStock Market Watch With Alerts Shows Unusual Activity - metal.it
Teva, Amneal End Case Over Listing Inhaler IP In Orange Book - Law360
Why Amneal Pharmaceuticals Inc. stock attracts strong analyst attentionAI Driven Stock Trend Forecast Shows Momentum Shift - metal.it
Amneal (AMRX) is an Incredible Growth Stock: 3 Reasons Why - sharewise.com
Wall Street Analysts Think Amneal (AMRX) Could Surge 43.82%: Read This Before Placing a Bet - Zacks Investment Research
Amneal Pharmaceuticals (AMRX) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
Q1 Earnings Highlights: Amneal, ANI, Amphastar, and ViatrisNews and Statistics - IndexBox
Q1 Earnings Highs And Lows: Amneal (NASDAQ:AMRX) Vs The Rest Of The Generic Pharmaceuticals Stocks - Yahoo Finance
Published on: 2025-07-29 09:45:24 - metal.it
Published on: 2025-07-28 20:38:28 - metal.it
Is Amneal Pharmaceuticals (AMRX) Outperforming Other Medical Stocks This Year? - Yahoo Finance
What institutional investors are buying Amneal Pharmaceuticals Inc. stockExceptional earning trajectories - jammulinksnews.com
How does Amneal Pharmaceuticals Inc. generate profit in a changing economyUnlock high-yield investment opportunities - jammulinksnews.com
How many analysts rate Amneal Pharmaceuticals Inc. as a “Buy”Achieve rapid financial growth with expert picks - jammulinksnews.com
How Amneal Pharmaceuticals Inc. stock performs during market volatilityFree Stock Selection with 300% Return - metal.it
Truist Financial Sticks to Its Buy Rating for Amneal Pharmaceuticals (AMRX) - The Globe and Mail
Amneal Pharmaceuticals Inc. Stock Analysis and ForecastMassive portfolio appreciation - PrintWeekIndia
Amneal Pharmaceuticals Prices $600M Senior Notes Offering - MSN
Truist Financial Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating, Announces Target Price $8 - 富途牛牛
Is Amneal Pharmaceuticals Inc. a good long term investmentPowerful profit generation - PrintWeekIndia
Amneal Pharmaceuticals prices $600 million in senior secured notes, increases term loan - Investing.com Nigeria
Amneal Pharmaceuticals prices $600 million in senior secured notes, increases term loan By Investing.com - Investing.com South Africa
Why Investors Shouldn't Be Surprised By Amneal Pharmaceuticals, Inc.'s (NASDAQ:AMRX) Low P/S - simplywall.st
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):